Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Remi Barbier$896.9M
Market Cap • 24/04/20241998
(há 26 anos)
2000
(24 years ago)
NASDAQ
Listagem
Austin
Sede • Texas26
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
SAVASó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.